Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001.

Autor: Hammond, Terese Catherine, Lee, Raymond C, Oronsky, Bryan, Reid, Tony R, Caroen, Scott, Juarez, Tiffany M, Gill, Jaya, Heng, Annie, Kesari, Santosh
Předmět:
Zdroj: International Medical Case Reports Journal; Dec2022, Vol. 15, p735-738, 4p
Abstrakt: Two critically ill COVID-19 infected patients, who had exhausted all available treatment options, were treated with the small-molecule RRx-001 with subsequent improvement. RRx-001, a first-in-class small molecule with anti-inflammatory, vascular normalizing and macrophage-repolarizing properties, has been safely administered 300+ patients in clinical trials. This is the first report of RRx-001 treatment of COVID-19. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index